Dr. David Liang, recently attended the 2024 ADLM (Association for Diagnostics & Laboratory Medicine) Exhibition in Chicago. Formerly known as AACC, the ADLM Exhibition stands as a leading global event for laboratory professionals, researchers, and industry pioneers, showcasing cutting-edge advancements in clinical diagnostics, laboratory technology, and medical innovation.
Drawing participants from across healthcare, diagnostics, biotechnology, and academic research sectors, the exhibition serves as a vital platform for thought leadership, networking, and collaborative exploration.
Dr. Liang’s participation at ADLM underscores Minnebio’s commitment to advancing laboratory medicine through innovative solutions designed for diagnostic applications and drug development. Leveraging our expertise in various bioreagents and cell culture media, Minnebio is dedicated to contributing to transformative developments in clinical diagnostics and precision medicine.
We are inspired by the knowledge and relationships cultivated during the event and remain focused on forging impactful partnerships to drive progress in laboratory medicine and biotechnology. Minnebio continues its mission to enhance the global diagnostic landscape through innovation and collaboration.